Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. Summary
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
09/17/2021 09/20/2021 09/21/2021 09/22/2021 09/23/2021 Date
2.62(c) 2.55(c) 2.59(c) 3.09(c) 3.01(c) Last
42 502 93 952 106 571 737 634 674 237 Volume
+1.16% -2.67% +1.57% +19.31% -2.59% Change
More quotes
Estimated financial data (e)
Sales 2021 36,7 M 28,9 M 28,9 M
Net income 2021 -0,33 M -0,26 M -0,26 M
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 48,6 M 38,3 M 38,3 M
Net income 2022 0,69 M 0,54 M 0,54 M
Net Debt 2022 - - -
P/E ratio 2022 134x
Yield 2022 -
Capitalization 323 M 255 M 254 M
Capi. / Sales 2021 8,78x
Capi. / Sales 2022 6,64x
Nbr of Employees 171
Free-Float 95,2%
More Financials
Company
Opsens Inc. provides fiber optic sensing technology. The Company operates through two segments: Medical and Industrial. In Medical segment, the Company focuses on the measure of Fractional Flow Reserve (FFR) in interventional cardiology. In Industrial segment, it develops, manufactures and installs fiber optic sensing solutions for critical applications, such as the monitoring of oil wells and other industrial... 
More about the company
Ratings of Opsens Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about OPSENS INC.
09/21OPSENS : Shares Rise 4% on Health Canada Approval, Raymond James Says Edwards Lifesciences..
MT
09/20OPSENS : Receives Health Canada Approval to Initiate First In-Man Clinical Study For Its S..
MT
09/20OPSENS : Receives Approval from Health Canada to Initiate First In-Man Clinical Study for ..
AQ
09/20OPSENS Receives Approval from Health Canada to Initiate First In-Man Clinical Study for..
CI
09/08OPSENS : Appoints Lori Chmura to its Board of Directors
AQ
09/08Opsens Inc. Appoints Lori Chmura to Board of Directors
CI
07/13Opsens Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021
CI
07/13OPSENS : Reports Q3 Loss Per Share of $0.01, Below Forecast
MT
07/13OPSENS BRIEF : Q3 Basic and Diluted Loss Per Share $0.01 Vs Forecast $0.00 As Per Capital ..
MT
07/13OPSENS : Announces Third Quarter Fiscal 2021 Record Financial Results
AQ
07/13NORTH AMERICAN MORNING BRIEFING : Investors Gear -2-
DJ
07/07OPSENS : to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesd..
AQ
06/16OPSENS : Gets Funding Support to Jointly Develop Optical-Based Fuel Monitoring System For ..
MT
06/16OPSENS : Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring Syst..
AQ
06/09OPSENS : will Participate and Present at two Investment Conferences - Lytham Partners and ..
AQ
More news
News in other languages on OPSENS INC.

- No features available -

More news
Analyst Recommendations on OPSENS INC.
More recommendations
Chart OPSENS INC.
Duration : Period :
Opsens Inc. Technical Analysis Chart | OPS | CA6838231083 | MarketScreener
Technical analysis trends OPSENS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 3,01 CAD
Average target price 3,79 CAD
Spread / Average Target 25,9%
EPS Revisions
Managers and Directors
Louis Laflamme President, Chief Executive Officer & Director
Robin Villeneuve Chief Financial Officer & Secretary
Alan W. Milinazzo Executive Chairman
Jean Lavigueur Independent Director
Denis L. Harrington Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPSENS INC.132.33%255
THERMO FISHER SCIENTIFIC30.24%239 289
DANAHER CORPORATION45.91%232 039
INTUITIVE SURGICAL, INC.27.72%124 326
SIEMENS HEALTHINEERS AG41.83%78 425
EDWARDS LIFESCIENCES CORPORATION31.16%75 435